N-[[5-methoxy-6-(2-methyl-4-pyridinyl)-3-pyridinyl]methyl]-4-(1,7-naphthyridin-6-yl)pyrimidin-2-amine
C25H21N7O — CID 129033206
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[[5-methoxy-6-(2-methyl-4-pyridinyl)-3-pyridinyl]methyl]-4-(1,7-naphthyridin-6-yl)pyrimidin-2-amine
N-[[5-methoxy-6-(2-methyl-4-pyridinyl)-3-pyridinyl]methyl]-4-(1,7-naphthyridin-6-yl)pyrimidin-2-amine (PubChem CID 129033206) has the molecular formula C25H21N7O and a molecular weight of 435.49 g/mol. Its IUPAC name is N-[[5-methoxy-6-(2-methyl-4-pyridinyl)-3-pyridinyl]methyl]-4-(1,7-naphthyridin-6-yl)pyrimidin-2-amine.
Molecular Properties
| Compound Name | N-[[5-methoxy-6-(2-methyl-4-pyridinyl)-3-pyridinyl]methyl]-4-(1,7-naphthyridin-6-yl)pyrimidin-2-amine |
|---|---|
| PubChem CID | 129033206 |
| Molecular Formula | C25H21N7O |
| Molecular Weight | 435.49 g/mol |
| Exact Mass | 435.18 |
| IUPAC Name | N-[[5-methoxy-6-(2-methyl-4-pyridinyl)-3-pyridinyl]methyl]-4-(1,7-naphthyridin-6-yl)pyrimidin-2-amine |
| SMILES | COc1cc(CNc2nccc(-c3cc4cccnc4cn3)n2)cnc1-c1ccnc(C)c1 |
| InChI | InChI=1S/C25H21N7O/c1-16-10-19(5-8-26-16)24-23(33-2)11-17(13-30-24)14-31-25-28-9-6-20(32-25)21-12-18-4-3-7-27-22(18)15-29-21/h3-13,15H,14H2,1-2H3,(H,28,31,32) |
| InChIKey | SRZKWINCNLFWEE-UHFFFAOYSA-N |
| XLogP | 4.47 |
| TPSA | 98.60 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 435.49 |
| LogP ≤ 5 | 4.47 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 129033206 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.